News & Press
LIFESCAPES Secures JPY 6bn to Accelerate Global Expansion and Clinical Trials
Japan FinTech Observer6/22/2026·06/22/26🌐 Asia
Summary
Tokyo-based LIFESCAPES, a medical technology startup spun out of Keio University, raised 600 million yen (approx. $3.8 million USD) through a third-party allotment. Investors include MSIVC2025V, Golden Asia Fund III, SUMISEI-SBI, and Mitsubishi UFJ Life Science Fund. The company develops medical devices utilizing BMI/BCI technology for neurorehabilitation targeting stroke paralysis.
Why it matters
LIFESCAPES represents Japan's growing academic-to-industry BCI pipeline, with strong participation from financial services investors signaling cross-sector confidence. The funding will support clinical trials needed for regulatory approval in Japan and global markets.
#BCI#Stroke Rehabilitation#Japan#Asia#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in